Arcutis Biotherapeutics announced strong third-quarter 2025 results, reporting revenue of $99.2 million and achieving profitability for the first time, which surpassed analyst expectations. Following ...

Presented new subgroup analyses from phase 3 clinical trial of CAN-2409 in localized prostate cancer at the American Society for Radiation ...

Check the structured 80-mark theory and 20-mark project scheme. Focus on Case Study-Based Questions and 6-mark Long Answers ...

Cornell researchers have developed a powerful new biosensor that reveals, in unprecedented detail, how and where ...

Tatler has unveiled its annual list of the most eligible young women in Britain and naturally it's awash with the daughters ...

Launched its first Asia office to support biotech and healthtech innovation and collaboration within the regionThe Asia ...